Rankings
▼
Calendar
ANIK Q4 2024 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$213M
Q4 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
-$1M
-103.0% YoY
Gross Profit
$23M
-1749.2% margin
Operating Income
$28M
-2156.4% margin
Net Income
-$22M
1695.0% margin
EPS (Diluted)
$-1.50
QoQ Revenue Growth
-103.3%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$275,000
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$203M
Total Liabilities
$49M
Stockholders' Equity
$154M
Cash & Equivalents
$56M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
-$1M
$43M
-103.0%
Gross Profit
$23M
$26M
-14.3%
Operating Income
$28M
-$64M
+143.6%
Net Income
-$22M
-$63M
+65.3%
Geographic Segments
UNITED STATES
$26M
77%
Europe
$8M
23%
← FY 2024
All Quarters
Q1 2025 →